Sponsored by the U.S. Department of Energy Human Genome Program
Human Genome News Archive Edition
In this issue...
Also available in pdf.
1997 Santa Fe Highlights
Human Genome Project Administration
In the News
Software and the Internet
Meeting Calendars & Acronyms
Sickle Cell Mice May Lead to New Treatments
Genetically engineered mice that mimic all the symptoms of human sickle cell disease were developed by a team led by Edward Rubin and Chris Paszty at LBNL (Science, October 31, 1997). This new mouse strain, which carries human hemoglobin with no counteracting mouse genes, provides a means for effective testing of experimental treatments. Each year, sickle cell disease afflicts about 100,000 babies, primarily of African descent, who endure the painful debilitating condition caused by a mutant hemoglobin gene. Other members of the team included Catherine Brion, Mary Stevens, and Mohandas Narla.
The electronic form of the newsletter may be cited in the following
The Human Genome Project (HGP) was an international 13-year effort, 1990 to 2003. Primary goals were to discover the complete set of human genes and make them accessible for further biological study, and determine the complete sequence of DNA bases in the human genome. See Timeline for more HGP history.
Published from 1989 until 2002, this newsletter facilitated HGP communication, helped prevent duplication of research effort, and informed persons interested in genome research.